Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sexually transmitted herpes simplex viruses.

Maria Karolina Jonsson1, Britta Wahren

  • 1Department of Virology, Swedish Institute for Infectious Disease Control, Microbiology and Tumour Biology Centre, Karolinska Institute, SE-171 82 Stockholm, Sweden. maria.jonsson@student.uib.no

Scandinavian Journal of Infectious Diseases
|April 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial.

Trials·2026
Same author

HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells.

Cancers·2023
Same author

Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev.

Molecular biology reports·2022
Same author

60 Years of viral vaccines.

Human vaccines & immunotherapeutics·2022
Same author

Cellular Immune Response Induced by DNA Immunization of Mice with Drug Resistant Integrases of HIV-1 Clade A Offers Partial Protection against Growth and Metastatic Activity of Integrase-Expressing Adenocarcinoma Cells.

Microorganisms·2021
Same author

Correction: DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response.

PloS one·2021
Same journal

Fas-Ligand Mediated Apoptosis in Severe Sepsis and Shock.

Scandinavian journal of infectious diseases·2017
Same journal

Lipopolysaccharide-inducible Gene Expression Profile in Human Monocytes.

Scandinavian journal of infectious diseases·2017
Same journal

Fatal varicella pneumonia.

Scandinavian journal of infectious diseases·2015
Same journal

Wissler's Syndrome Associated with Parainfluenza 2 Infection.

Scandinavian journal of infectious diseases·2015
Same journal

Contamination of smears with "sergentella spiroides".

Scandinavian journal of infectious diseases·2015
Same journal

Recrudescent typhus: fluctuations in titers of complement-fixing and microagglutinating antibodies to rickettsia prowazeki in persons with a history of epidemic typhus.

Scandinavian journal of infectious diseases·2015
See all related articles

Genital herpes infections are increasingly caused by herpes simplex virus type 1 (HSV-1), which may offer protection against herpes simplex virus type 2 (HSV-2). Rising prevalence is linked to sexual behaviors, impacting other sexually transmitted diseases.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Herpes simplex virus type 2 (HSV-2) is the primary cause of genital ulcerative infections.
  • Genital herpes infections are typically acquired through sexual contact.
  • A growing number of genital infections are now attributed to herpes simplex virus type 1 (HSV-1).

Purpose of the Study:

  • To analyze the changing landscape of genital herpes simplex virus infections.
  • To investigate the clinical characteristics and recurrence rates of genital HSV-1 versus HSV-2.
  • To explore the potential protective effects of HSV-1 against HSV-2 and its impact on overall HSV-2 prevalence.

Main Methods:

  • Review of epidemiological data on genital herpes simplex virus infections.
  • Clinical comparison of genital HSV-1 and HSV-2 infections.

Related Experiment Videos

  • Analysis of potential cross-protective immunity between HSV-1 and HSV-2.

    • Main Results:

    • Genital HSV-1 infections are generally less severe and recur less frequently than HSV-2 infections.
    • HSV-1 infection may provide some protection against HSV-2 acquisition and mitigate disease severity.
    • The impact of genital HSV-1 on the overall prevalence of HSV-2 remains unclear.

    Conclusions:

    • Increased sexual promiscuity and advanced sexual techniques contribute to the rise in genital herpes simplex virus prevalence.
    • Efforts to curb herpes virus transmission can influence the spread of other chronic diseases like HIV.
    • Public health strategies addressing sexual transmission are crucial for managing genital herpes and associated diseases.